H1 Antihistamines: Definition and Classification
H1 antihistamines are medications that act as inverse agonists at histamine H1 receptors, stabilizing the inactive conformation of these receptors to prevent histamine from causing allergic symptoms. They are not simply "blockers" or "antagonists" as traditionally described, but rather inverse agonists that can down-regulate constitutive receptor activity even in the absence of histamine 1, 2.
Two Generations with Distinct Properties
First-Generation H1 Antihistamines
These older agents include:
- Diphenhydramine
- Hydroxyzine
- Chlorpheniramine
- Cyproheptadine (with additional antiserotonergic activity)
Critical limitation: First-generation agents cross the blood-brain barrier extensively, causing significant sedation, cognitive impairment, and impaired driving ability 1. They also have problematic anticholinergic effects and are associated with cognitive decline, particularly dangerous in elderly populations 1. Their use is now discouraged as monotherapy for allergic conditions due to these safety concerns 3.
Second-Generation H1 Antihistamines
These newer agents include:
- Fexofenadine
- Cetirizine
- Loratadine
- Desloratadine
- Levocetirizine
Second-generation antihistamines are preferred because they minimally cross the blood-brain barrier, have longer duration of action, minimal anticholinergic effects, and significantly less sedation 2. They have been extensively studied for clinical pharmacology, efficacy, and safety—unlike first-generation agents that were never optimally investigated despite decades of use 1.
Mechanism and Clinical Effects
H1 antihistamines work by combining with and stabilizing the inactive conformation of H1 receptors, shifting the equilibrium away from the activated state 1. They are effective for treating:
- Cutaneous symptoms: pruritus, flushing, urticaria
- Dermatologic manifestations in mast cell disorders
- Tachycardia and abdominal discomfort (to lesser extent)
However, antihistamines are poorly effective for cardiovascular and respiratory symptoms like hypotension or bronchospasm when used as monotherapy 2. When given orally, onset of action may occur within 30 minutes, but peak plasma concentrations aren't reached until 60-120 minutes, with an additional 60-90 minutes needed for maximal tissue effect 2.
Clinical Positioning
Second-generation H1 antihistamines work best as prophylactic rather than acute treatment—once histamine-mediated symptoms are apparent, it's too late to effectively block histamine binding to receptors 1. In conditions like mast cell activation syndrome, these agents (particularly fexofenadine and cetirizine) are often used at 2-4 times FDA-approved doses 1.
For anaphylaxis specifically: antihistamines should never be administered before or in place of epinephrine, as they lack vasoconstrictive, bronchodilatory, inotropic, and mast cell stabilization properties 2. They serve only as adjunctive therapy after epinephrine administration.
Important Safety Considerations
- Avoid first-generation agents in elderly patients due to cognitive decline risk 1
- Cetirizine may be sedating at higher doses 3
- Dose adjustments needed in renal/hepatic impairment 3
- Best avoided in pregnancy, though chlorpheniramine often chosen when necessary due to safety record 3
- Anticholinergic effects of certain agents worsen cognitive outcomes, particularly concerning in elderly populations 1